James Peyer, Director, 10% Owner at Sensei Biotherapeutics, Inc. (SNSE), bought 22,000 shares at $5.27 ($116K) on 2021-12-23, disclosed to the SEC on 2021-12-23.
Open-market purchase of $116k SNSE by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.27 | 11,000 | $58K | 50.0% |
| 2 | $5.27 | 11,000 | $58K | 50.0% |
| Total | $5.27 avg | 22,000 | $116K | 100% |
| Filing → |
| SNSE | SELL | 2025-12-08 | $398K | — | Filing → |
| SNSE | BUY | 2022-04-21 | $15K | — | Filing → |
| SNSE | BUY | 2022-04-21 | $136K | — | Filing → |